The European Union is one of the world’s largest and most highly regulated medical device markets, serving over 500 million consumers and generating more than €150 billion annually. Achieving MDR or IVDR compliance is essential — but it’s only the first step. To legally place your device on the EU market, you must appoint a qualified EU-based Local Representative. At CMS SciDoc, we deliver reliable, fully compliant, and responsive EU Local Representative services tailored to:💠 Medical Devices (MDR 2017/745)💠In Vitro Diagnostics (IVDR 2017/746)💠Software as a Medical Device (SaMD)💠Startups and Global Manufacturers With over 33% of global medtech revenue generated in Europe, the opportunity is significant. Our expertise ensures not only[…]
Tag: sponsor
Strengthen Your QMS. Simplify Compliance. Succeed in the Market.
From startups preparing for ISO 13485 certification to established manufacturers upgrading their Quality Management System, CMS SciDoc delivers practical, end-to-end regulatory and quality solutions that drive compliance and performance. Our Services Include:🔹 QMS Setup & Optimization – Built to meet ISO 13485, MDR, IVDR, MDSAP, and global regulatory frameworks🔹 Quality Documentation Packages – SOPs, Quality Manuals, CAPA workflows, Risk Management files, and technical documentation🔹 Gap Reviews & Internal Audits – Proactive compliance checks to keep you inspection-ready🔹 Team Training & Expert Guidance – Clear, actionable support to build in-house regulatory capability Move forward with confidence — from compliance planning to audit success. 📞 Schedule your free consultation📧 info@cmsscidoc.com
Cosmetics GMP for Export Purposes (ISO 22716) – Responsible Person
C | M | S can now act as your European responsible Person. If you are a cosmetics exporter, you may have had been notified by mandated bodies that you require to comply with EC Regulation 1223/2009. What are the requirements for this regulation? All cosmetic products exported to Europe/Asia/NZ will have to be produced according to Good Manufacturing Practices. Cosmetics Good Manufacturing Practices (GMP) is one of the pillars of the New European Regulation for Cosmetics. This regulation sets the requirements to ensure consumers’ safety. Amongst these new legal requirements, all cosmetic products circulating onto the European Market will have to be produced according to Good Manufacturing Practices; a Product Information[…]
Medical Device Single Audit Program (MDSAP) – TGA, CE Marking and more……………………
Achieve access to multiple markets with a single audit The International Medical Device Regulators Forum (IMDRF) established a working group to develop a standard set of requirements for auditing organizations (Certification Bodies) performing regulatory audits of Medical Device manufacturers’ quality management systems. Termed the Medical Device Single Audit Program (MDSAP), the requirements will be applicable to regulatory authorities, as well as third-party organizations that conduct such audits. What is the MDSAP? The objective of the MDSAP is to develop, manage, and oversee a single audit program that will allow a single regulatory audit of a Medical Device manufacturer, conducted by an MDSAP recognized auditing organization, to satisfy the needs of[…]
Top Reasons to Choose Compliance Management Solutions as Your TGA Sponsor
Why Partner with Compliance Management Solutions as Your Australian TGA Sponsor Navigating Australia’s Therapeutic Goods Administration (TGA) regulatory framework requires more than a local presence—it demands regulatory expertise, responsiveness, and accountability. Compliance Management Solutions (CMS) provides medical device manufacturers with a reliable, experienced, and commercially pragmatic Australian TGA Sponsor solution. As your TGA Sponsor, CMS acts as a seamless extension of your regulatory team, supporting ARTG inclusion, ongoing compliance, post-market obligations, and direct regulatory liaison with the TGA. We ensure your devices are correctly classified, supported by appropriate conformity assessment evidence, and maintained in compliance throughout their lifecycle in Australia. CMS brings a strong understanding of both international regulatory frameworks[…]
MDR 2017/745 and IVDR 2017/746 EU Authorised Representative & EU Importer Services
Compliance Management Solutions Europe Medical device manufacturers seeking access to the European Union market must comply with the regulatory obligations of MDR (EU) 2017/745, including the appointment of a compliant EU Authorised Representative and, where applicable, an EU Importer. Compliance Management Solutions Europe provides integrated EU Rep and EU Importer services designed to support lawful market access, regulatory continuity, and post-market compliance. As an EU Authorised Representative, Compliance Management Solutions Europe fulfils the responsibilities outlined in Article 11 of the MDR, acting as the manufacturer’s official regulatory presence within the EU. We support manufacturers by verifying the availability and completeness of technical documentation and Declarations of Conformity, maintaining regulatory records,[…]
Transfer Your EU MDR and IVDR Authorized Representative & Importer to CMS – Simplify EU Compliance
If you manufacture products outside the European Union and sell into the EU market, having a reliable EU Authorized Representative and EU Importer is not optional—it is a regulatory requirement. CMS helps non-EU manufacturers seamlessly transfer their EU Authorized Representative and Importer while ensuring full compliance with EU MDR, IVDR, CE Marking, and EU product regulations. Why Transfer Your EU Rep and Importer to CMS? ✔ Fast EU Authorized Representative transfer with minimal disruption✔ Single, trusted EU Importer and Authorized Representative under one contract✔ Full support for MDR, IVDR, medical devices, IVDs, and regulated products✔ Expertise in CE marking, EU compliance, technical documentation, and vigilance✔ Clear communication, transparent pricing, and[…]
Australian TGA Medical Device Sponsor
As per the Australian TGA Medical Device Regulations, before an individual or company can supply a medical device for sale in Australia, they are required to make an application to include the item in the Australian Register of Therapeutic Goods (ARTG). This registration is crucial for ensuring that the medical devices comply with Australian health standards and are safe for use by the public. The sponsor is defined as the person or company responsible for the importation of therapeutic goods into Australia, playing a vital role in the compliance process. The importance of having a reliable sponsor cannot be overstated. A well-informed sponsor familiar with Australian regulations can expedite the[…]
This New Year, invest in your professional growth and strengthen your regulatory knowledge to stay ahead in the dynamic world of medical devices.
CMS SciDoc invites Expressions of Interest for our Medical Device Training Programmes – 2026, designed to empower professionals with practical expertise and up-to-date insights into global regulatory requirements.Our programs are crafted and delivered by experienced medical device consultants, blending regulatory theory with real-world, hands-on application to help you achieve compliance confidence. Who should attend?💠 Regulatory Affairs & Quality professionals💠 Medical device manufacturers & sponsors💠 Start-ups entering the medical device market💠 R&D, Clinical, QA/RA, and Compliance teams Proposed training topics:💠 ISO 13485 – Quality Management Systems for Medical Devices💠 ISO 14971 – Risk Management for Medical Devices💠 Process Validation for Medical Devices💠 Medical Device Software💠 Auditor Training💠 Designing a Regulatory Compliant Technical File💠 Clinical Evaluation Report: Tips & Tricks💠 MDSAP[…]
FDA draft guidance for biocompatibility assessment
FDA published the draft guidance on chemical analysis for biocompatibility assessment of medical devices on September 20, 2024. This guidance provides recommendations for the collection and reporting of chemical characterization data that should be used to support medical device market clearance.